Studies have shown that KLRK1 activates NK cells and inhibits lung cancer proliferation and metastasis by controlling lung cancer through immune surveillance, thereby improving the prognosis, which is consistent with our findings (54). Here, KLRK1 is linked to lung carcinoma.